Serial MR evaluation of brain atrophy in patients with cerebral vascular disease

XIE Sheng,XIAO Jiang-xi,WANG Wei,HUANG Yi-ning,JIANG Xue-xiang
DOI: https://doi.org/10.3321/j.issn:1003-3289.2008.05.001
2008-01-01
Abstract:Objective To estimate the brain atrophy rates in patients with cerebral vascular disease by using SIENA software, and analyze the risk factors. Methods One hundred and thirty-eight patients with cerebral vascular disease underwent MR scanning twice one year apart, at the baseline and at the end of the follow-up period. The clinical data of all patients, including age, systolic blood pressure, blood glucose level, serum lipid level and alcohol consumption and smoking were recorded at baseline, as well as historical information concerning hypertension, diabetes mellitus and hypercholesterolemia. Besides, clinical rating of Mini-mental State Examination (MMSE) and the National Institute of Health Stroke Scale were conducted for every patient. Their T1W images at both time points were processed automatically with SIENA software to determine the percent brain volume change (PBVC). MRI measures included volume of newly-onset gray matter and white matter infarction, and baseline volume of white matter hyperintensity (WMH). The influence of risk factors on PBVC was analyzed by using regression analysis. Correlation coefficients were calculated between clinical scales and PBVC. Results The PBVC was -0.77%±0.81% for the patients, and the initial WMH volume was (13 155±18 782)mm3, the volume of newly-onset infarction was(5 081±12 709)mm3。Regression analysis revealed that PBVC was affected by the age, and the presence of newly-onset gray matter and white matter infarction. PBVC was correlated significantly with MMSE (r=0.27,P=0.001), while it was correlated reversely with NIHSS (r=-0.18, P=0.036). There was a significant relationship between the PBVC and volume of newly-onset infarction (r=-0.44, P=0.000). Conclusion Age and newly-onset infarction may have an effect on the brain atrophy in patients with cerebral vascular disease. SIENA software identifies brain atrophy quantitatively, which may provide useful information for clinical evaluation.
What problem does this paper attempt to address?